title: Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1)  levels in a p53-independent manner.
abstract: It is now largely accepted that ribosomal proteins may be implicated in a variety of biological functions besides that of components of the translation machinery. Many evidences show that a subset of ribosomal proteins are involved in the regulation of the cell cycle and apoptosis through modulation of p53 activity. In addition, p53-independent mechanisms of cell cycle arrest in response to alterations of ribosomal proteins availability have been described. Here, we identify human rpL3 as a new regulator of cell cycle and apoptosis through positive regulation of p21 expression in a p53-independent system. We demonstrate that the rpL3-mediated p21 upregulation requires the specific interaction between rpL3 and Sp1. Furthermore, in our experimental system, p21 overexpression leads to a dual outcome, activating the G₁/S arrest of the cell cycle or the apoptotic pathway through mitochondria, depending on its intracellular levels. It is noteworthy that depletion of p21 abrogates both effects. Taken together, our findings unravel a novel extraribosomal function of rpL3 and reinforce the proapoptotic role of p21 in addition to its widely reported ability as an inhibitor of cell proliferation.
authors.affiliation: Dipartimento di Biochimica e Biotecnologie Mediche; Università Federico II, Naples, Italy.
authors.forename: Annapina
authors.initials: A
authors.lastname: Russo
authors.forename: Davide
authors.initials: D
authors.lastname: Esposito
authors.forename: Morena
authors.initials: M
authors.lastname: Catillo
authors.forename: Concetta
authors.initials: C
authors.lastname: Pietropaolo
authors.forename: Elvira
authors.initials: E
authors.lastname: Crescenzi
authors.forename: Giulia
authors.initials: G
authors.lastname: Russo
mesh_terms: D017209:Apoptosis; D045744:Cell Line, Tumor; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D059585:G1 Phase Cell Cycle Checkpoints; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D000090243:Nucleophosmin; D011401:Promoter Regions, Genetic; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D000090822:Ribosomal Protein L3; D012269:Ribosomal Proteins / Q000235:genetics / Q000378:metabolism*; D059807:S Phase Cell Cycle Checkpoints; D016329:Sp1 Transcription Factor / Q000235:genetics / Q000378:metabolism; D015533:Transcriptional Activation; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; D009687:Nuclear Proteins; D034741:RNA, Small Interfering; C000716547:RPL3 protein, human; D000090822:Ribosomal Protein L3; D012269:Ribosomal Proteins; D016329:Sp1 Transcription Factor; D016159:Tumor Suppressor Protein p53; D000090243:Nucleophosmin